ask="7.9000"
ask_size="1100"
average_daily_volume="31364"
bid="3.1200"
bid_size="100"
book_value="3.3400"
change="-0.1296"
change_from_200_day_moving_average="1.1331"
change_from_50_day_moving_average="2.0468"
change_from_52_week_high="-2.0767"
change_From_52_week_low="4.1904"
change_in_percent="-1.6531%"
close="7.7104"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.2620"
ebitda="-50.28M"
eps_estimate_current_year="-2.6000"
eps_estimate_next_quarter="-0.6300"
eps_estimate_next_year="-2.8400"
ex_dividend_date="N/A"
float_shares="686000"
high="7.8400"
high_52_weeks="9.7871"
last_trade_date="1/19/2017"
last_trade_price="7.7104"
last_trade_size="500"
last_trade_time="3:33pm"
low="7.7000"
low_52_weeks="3.5200"
market_capitalization="164.08M"
moving_average_200_day="6.5773"
moving_average_50_day="5.6636"
name="Nabriva Therapeutics AG - Ameri"
notes="N/A"
one_year_target_price="16.1900"
open="7.7200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+17.2276%"
percent_change_from_50_day_moving_average="+36.1400%"
percent_change_from_52_week_high="-21.2187%"
percent_change_from_52_week_low="+119.0455%"
previous_close="7.8400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.3473"
price_per_sales="32.0830"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.7500"
stock_exchange="NMS"
symbol="NBRV"
volume="10513"
weeks_range_52="3.5200 - 9.7871"
